CIK 0001490978
- Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954284541
- Phone
- +1 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,781,663
- in 3 filings, $2.8M under 10b5-1 plans
Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-09 | Daniel Jennifer SVP & Chief HR Officer | Exercise or conversion · Stock Option (right to buy) | −2,006 | 34,113 | ||
| 2021-02-08 | Daniel Jennifer SVP & Chief HR Officer | Exercise or conversion | +2,006 | $17.00 | $34K | 8,694 |
| 2021-02-08 | Daniel Jennifer SVP & Chief HR Officer | Sale | −2,006 | $100.00 | $201K | 6,688 |
| 2021-02-08 | Daniel Jennifer SVP & Chief HR Officer | Exercise or conversion · Stock Option (right to buy) | −2,006 | 36,119 | ||
| 2021-02-05 | Lebowitz Joel | Sale | −1,115 | $99.90 | $111K | 0 |
| 2021-02-05 | Daniel Jennifer SVP & Chief HR Officer | Exercise or conversion | +2,006 | $17.00 | $34K | 8,694 |
| 2021-02-05 | Daniel Jennifer SVP & Chief HR Officer | Sale | −2,006 | $99.80 | $200K | 6,688 |
| 2021-02-05 | Daniel Jennifer SVP & Chief HR Officer | Exercise or conversion · Stock Option (right to buy) | −2,006 | 38,125 | ||
| 2021-02-05 | Abel Robert Lorne EVP, Science | Exercise or conversion | +4,992 | $2.92 | $15K | 4,992 |
| 2021-02-05 | Abel Robert Lorne EVP, Science | Exercise or conversion | +10,881 | $1.57 | $17K | 15,873 |
| 2021-02-05 | Abel Robert Lorne EVP, Science | Sale | −3,108 | $97.73 | $304K | 12,765 |
| 2021-02-05 | Abel Robert Lorne EVP, Science | Sale | −5,078 | $99.05 | $503K | 7,687 |
| 2021-02-05 | Abel Robert Lorne EVP, Science | Sale | −7,687 | $99.75 | $767K | 0 |
| 2021-02-05 | Abel Robert Lorne EVP, Science | Exercise or conversion · Stock Option (right to buy) | −4,992 | 2,214 | ||
| 2021-02-05 | Abel Robert Lorne EVP, Science | Exercise or conversion · Stock Option (right to buy) | −10,881 | 2,496 | ||
| 2021-02-05 | Lebowitz Joel EVP & CFO | Exercise or conversion | +12,374 | $17.00 | $210K | 12,374 |
| 2021-02-05 | Lebowitz Joel EVP & CFO | Sale | −900 | $97.90 | $88K | 11,474 |
| 2021-02-05 | Lebowitz Joel EVP & CFO | Sale | −10,359 | $99.18 | $1.0M | 1,115 |
| 2021-02-05 | Lebowitz Joel EVP & CFO | Purchase | −1,115 | $99.90 | $111K | 0 |
| 2021-02-05 | Lebowitz Joel EVP & CFO | Exercise or conversion · Stock Option (right to buy) | −12,374 | 37,122 |
Page 40 of 60 · 1,192 trades